BiomeBank Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10M
- Investors
-
6
BiomeBank General Information
Description
Operator of a biotechnology company intended to facilitate microbial therapies. The company uses a unique combination of machine learning and microbiology to identify bacterial strains that influence disease and is developing a pipeline of microbiome therapies, enabling doctors to treat and prevent disease by restoring gut microbial ecology.
Contact Information
Website
www.biomebank.comCorporate Office
- Level 3, 21-24 North Terrace
- Adelaide, South Australia 5000
- Australia
Corporate Office
- Level 3, 21-24 North Terrace
- Adelaide, South Australia 5000
- Australia
BiomeBank Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 16-Apr-2026 | $10M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 02-Nov-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 30-Jun-2021 | Completed | Clinical Trials - General | |||
| 2. Grant | 24-Jun-2021 | $100K | $500K | Completed | Startup | |
| 1. Seed Round | 04-Dec-2018 | $500K | $500K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BiomeBank Patents
BiomeBank Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025904346-A0 | Lyophilized compositions | Pending | 18-Sep-2025 | ||
| AU-2025900416-A0 | Novel co-cultured microbial consortia and methods | Inactive | 14-Feb-2025 | ||
| AU-2024902944-A0 | Microbiota compositions and methods for treating disorders | Inactive | 16-Sep-2024 | ||
| WO-2026036185-A1 | Novel co-cultured microbial consortia and methods | Pending | 16-Aug-2024 | ||
| AU-2025236357-A1 | Microbiota compositions and methods for treating disorders | Pending | 15-Mar-2024 | A61K35/74 |
BiomeBank Signals
BiomeBank Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Blackmores | Corporation | Minority | ||
| Ellerston Capital | Asset Manager | Minority | ||
| South Australian Venture Capital Fund | Venture Capital | Minority | ||
| Innovative Manufacturing Cooperative Research Centre | Government | |||
| Artesian | Venture Capital | Minority |
BiomeBank FAQs
-
When was BiomeBank founded?
BiomeBank was founded in 2016.
-
Where is BiomeBank headquartered?
BiomeBank is headquartered in Adelaide, Australia.
-
What is the size of BiomeBank?
BiomeBank has 37 total employees.
-
What industry is BiomeBank in?
BiomeBank’s primary industry is Pharmaceuticals.
-
Is BiomeBank a private or public company?
BiomeBank is a Private company.
-
What is the current valuation of BiomeBank?
The current valuation of BiomeBank is .
-
What is BiomeBank’s current revenue?
The current revenue for BiomeBank is .
-
How much funding has BiomeBank raised over time?
BiomeBank has raised $42.7M.
-
Who are BiomeBank’s investors?
Blackmores, Ellerston Capital, South Australian Venture Capital Fund, Innovative Manufacturing Cooperative Research Centre, and Artesian are 5 of 6 investors who have invested in BiomeBank.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process